(Axios) – The Federal Trade Commission on Monday launched an inquiry into whether health providers are failing to disclose risks connected with gender-affirming care or are making false claims about its benefits.

Why it matters: The action could help make the case for using unfair competition laws to crack down on health providers, by asserting gender-affirming care involves deceptive claims, legal analysts say. (Read More)